Clinical trial
Cardiovascular Risk Reduction in Atrial Fibrillation Trial
NCT04347330 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiovascular Risk Reduction in Atrial Fibrillation Trial
- Lead sponsor
- Beijing Anzhen Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2020
- Completion date
- December 31, 2025
- Enrollment
- 1,675 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.